exploring frontiers of bioscience
The Paul G. Allen Frontiers Group explores the landscape of science to identify and invest in pioneers with ideas that will create new knowledge and make the world better. Through continuous dialogue with scientists and visionaries around the world, the Frontiers Group will uncover novel ideas in bioscience with the potential to transform fields. The Frontiers Group will help to create new ways of doing science, new ways of solving problems, and foster a creative community that imagines and creates the future.
We engage with scientists and visionaries around the world to uncover and make visible emerging frontiers and new directions in science. We convene creative partners in novel ways to imagine possible futures.
Funding new ideas
We invest in investigators and centers for frontier explorations that lead to new fundamental insights and produce important solutions with big impact.
We link ideas across the landscape of quantitative fields now addressing bioscience research and seek out creative approaches that span disciplines.
News from The Paul G. Allen Frontiers Group
New CRISPR-based technique in mice upends rules of genetic inheritance
January 23, 2019
‘Active genetics,’ the parent technique of controversial gene drives, could speed biomedical research, improve mouse models of human disease
2018 Highlights from the Frontiers Group
December 20, 2018
A new collaboration to combat cognitive decline, reflections on founder Paul G. Allen’s impact, and more from the Frontiers Group this year
Research teams from Salk Institute for Biological Studies, Stanford University, University Hospitals Cleveland Medical Center selected to study healthy brain aging, better treatments for neurodegenerative diseases
November 9, 2018
The American Heart Association and Allen Institute announce $43 million commitment in research funding for innovative approaches to combat age-related dementia, including Alzheimer’s disease